ARMISTICE CAPITAL, LLC - VIRAX BIOLABS GROUP LTD ownership

VIRAX BIOLABS GROUP LTD's ticker is and the CUSIP is G9495L109. A total of 6 filers reported holding VIRAX BIOLABS GROUP LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of VIRAX BIOLABS GROUP LTD
ValueSharesWeighting
Q1 2023$1,043,1001,500,0000.02%
Other shareholders
VIRAX BIOLABS GROUP LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 48,458$350.01%
Riggs Asset Managment Co. Inc. 4$30.00%
UBS Group AG 6,185$4,5150.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 102,608$73,4750.00%
MILLENNIUM MANAGEMENT LLC 15,395$110.00%
MORGAN STANLEY 853$6230.00%
Renaissance Technologies 11,400$80.00%
View complete list of VIRAX BIOLABS GROUP LTD shareholders